Journal article icon

Journal article

Humoral and cellular immunity to RSV in infants, children and adults

Abstract:

Background Respiratory syncytial virus (RSV) causes respiratory disease throughout life. Here we report differences in naturally acquired immunity with age and presumed exposure.

Methods A longitudinal, non-interventional, observational study was performed in healthy adults (20 paediatric healthcare workers and 10 non-healthcare workers), children (10 aged 3–6 years) and infants (5 aged 2–4 months and 20 aged 6–12 months). Blood samples were analysed for RSV-neutralising antibody titre, F/Ga/Gb-specific antibody titres, F-specific IgG/IgA memory B-cell frequencies and T-cell production of IFNγ, IL-4, IL-13 and IL-17.

Results Serum G-specific antibody titres were significantly lower in infants and children than adults. However, serum titres of F-specific and RSV-neutralising antibody and IFNγ-producing T-cell frequencies were low or absent in the infants, but comparable between children and adults. Interestingly, F-specific memory IgA B-cells could not be detected in paediatric samples and in samples from non-healthcare workers, but recordable IgA memory B-cells were found in 9/18 paediatric healthcare workers and 2/8 non-healthcare workers at the end of the RSV season. These responses waned 4–6 months later. By contrast, F-specific IgG memory B-cells were detectable in samples from all adults without significant variation across time points. T-cells producing IL-4, IL-13 and IL-17 responses were not detectable in peripheral blood from a subset of volunteers.

ConclusionsRepeated RSV exposure in early life generates immune responses that are inversely related to frequency of severe disease. Induction of F-specific antibody and cellular immune responses through infant vaccination might help to accelerate the development of protective immune responses at an early age.

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1016/j.vaccine.2018.08.056

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Paediatrics
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Paediatrics
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Paediatrics
Role:
Author


Publisher:
Elsevier
Journal:
Vaccine More from this journal
Volume:
36
Issue:
41
Pages:
6183-6190
Publication date:
2018-08-31
Acceptance date:
2018-08-21
DOI:
EISSN:
1873-2518
ISSN:
0264-410X
Pmid:
30177258


Language:
English
Keywords:
Pubs id:
pubs:912259
UUID:
uuid:906348d6-c26a-4ae0-b46f-6165820d1db4
Local pid:
pubs:912259
Source identifiers:
912259
Deposit date:
2018-09-08

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP